Therapeutic exploitation of necroptosis for cancer therapy

Seminars in Cell and Developmental Biology

Volumn 35, Issue , 2014, Pages 51-56

  Fulda, Simone ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cancer; Necroptosis; Programmed cell death; RIP1; Signal transduction

Indexed keywords

4 (8 CYCLOPENTYL 7 ETHYL 5,6,7,8 TETRAHYDRO 5 METHYL 6 OXO 2 PTERIDINYLAMINO) 3 METHOXY N (1 METHYL 4 PIPERIDINYL)BENZAMIDE; 5 AZA 2' DEOXYCYTIDINE; AMILORIDE; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; AZACITIDINE; CISPLATIN; FINGOLIMOD; GIVINOSTAT; GREEN TEA EXTRACT; NAPHTHOQUINONE; NUCLEAR RECEPTOR COACTIVATOR 2; OBATOCLAX; SHIKONIN; STAUROSPORINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; BREAST CARCINOMA; CANCER CELL; CANCER RADIOTHERAPY; CANCER THERAPY; CELL DEATH; GLIOBLASTOMA; GLIOMA; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CARCINOMA; NECROPTOSIS; NEUROBLASTOMA; NONHUMAN; OVARY CARCINOMA; PHOTODYNAMIC THERAPY; PROSTATE CARCINOMA; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; THYROID CANCER; DRUG EFFECTS; METABOLISM; NECROSIS; NEOPLASMS; PATHOPHYSIOLOGY; PROCEDURES; RADIATION RESPONSE; RADIOTHERAPY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; NECROSIS; NEOPLASMS; RADIOTHERAPY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84908666232     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.07.002     Document Type: Review

References (76)

1. Lockshin R.A., Zakeri Z. Cell death in health and disease. J Cell Mol Med 2007, 11:1214-1224.
2. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19:107-120.
3. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
4. Vanden Berghe T., Linkermann A., Jouan-Lanhouet S., Walczak H., Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014, 15:135-147.
5. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1:489-495.
6. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
7. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
8. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.
9. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
10. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471:373-376.
11. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998, 188:919-930.
12. Matsumura H., Shimizu Y., Ohsawa Y., Kawahara A., Uchiyama Y., Nagata S. Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000, 151:1247-1256.
13. Meurette O., Rebillard A., Huc L., Le Moigne G., Merino D., Micheau O., et al. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions. Cancer Res 2007, 67:218-226.
14. Chen M.C., Hwang M.J., Chou Y.C., Chen W.H., Cheng G., Nakano H., et al. The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death. J Biol Chem 2003, 278:16073-16081.
15. May M.J., Madge L.A. Caspase inhibition sensitizes inhibitor of NF-kappaB kinase beta-deficient fibroblasts to caspase-independent cell death via the generation of reactive oxygen species. J Biol Chem 2007, 282:16105-16116.
16. Vince J.E., Chau D., Callus B., Wong W.W., Hawkins C.J., Schneider P., et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 2008, 182:171-184.
17. Ikner A., Ashkenazi A. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8. J Biol Chem 2011, 286:21546-21554.
18. Wilson C.A., Browning J.L. Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 2002, 9:1321-1333.
19. Vanden Berghe T., Vanlangenakker N., Parthoens E., Deckers W., Devos M., Festjens N., et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010, 17:922-930.
20. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1:112-119.
21. Northington F.J., Chavez-Valdez R., Graham E.M., Razdan S., Gauda E.B., Martin L.J. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011, 31:178-189.
22. Smith C.C., Davidson S.M., Lim S.Y., Simpkin J.C., Hothersall J.S., Yellon D.M. Necrostatin: a potentially novel cardioprotective agent?. Cardiovasc Drugs Ther 2007, 21:227-233.
23. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
24. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
25. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297:259-263.
26. Xu X., Chua C.C., Kong J., Kostrzewa R.M., Kumaraguru U., Hamdy R.C., et al. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 2007, 103:2004-2014.
27. Buytaert E., Dewaele M., Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007, 1776:86-107.
28. Schildkopf P., Frey B., Mantel F., Ott O.J., Weiss E.M., Sieber R., et al. Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 2010, 391:1014-1020.
29. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., et al. The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43:432-448.
30. Vantieghem A., Assefa Z., Vandenabeele P., Declercq W., Courtois S., Vandenheede J.R., et al. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett 1998, 440:19-24.
31. Lenardo M.J., Angleman S.B., Bounkeua V., Dimas J., Duvall M.G., Graubard M.B., et al. Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J Virol 2002, 76:5082-5093.
32. Petit F., Arnoult D., Lelievre J.D., Moutouh-de Parseval L., Hance A.J., Schneider P., et al. Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. J Biol Chem 2002, 277:1477-1487.
33. Peri P., Nuutila K., Vuorinen T., Saukko P., Hukkanen V. Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells. J Gen Virol 2011, 92:173-180.
34. Chu J.J., Ng M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J Gen Virol 2003, 84:3305-3314.
35. Bolton D.L., Hahn B.I., Park E.A., Lehnhoff L.L., Hornung F., Lenardo M.J. Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J Virol 2002, 76:5094-5107.
36. Arjona A., Ledizet M., Anthony K., Bonafe N., Modis Y., Town T., et al. West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J Immunol 2007, 179:8403-8409.
37. Li M., Beg A.A. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol 2000, 74:7470-7477.
38. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
39. Zhao J., Jitkaew S., Cai Z., Choksi S., Li Q., Luo J., et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 2012, 109:5322-5327.
40. Wang H., Sun L., Su L., Rizo J., Liu L., Wang L.F., et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 2014, 54:133-146.
41. Dondelinger Y., Declercq W., Montessuit S., Roelandt R., Goncalves A., Bruggeman I., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 2014, 7:971-981.
42. Wang Z., Jiang H., Chen S., Du F., Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012, 148:228-243.
43. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010, 11:700-714.
44. Ono K., Kim S.O., Han J. Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death. Mol Cell Biol 2003, 23:665-676.
45. Yamashima T., Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 2009, 89:343-358.
46. Thon L., Mohlig H., Mathieu S., Lange A., Bulanova E., Winoto-Morbach S., et al. Ceramide mediates caspase-independent programmed cell death. FASEB J 2005, 19:1945-1956.
47. Won J.S., Singh I. Sphingolipid signaling and redox regulation. Free Radic Biol Med 2006, 40:1875-1888.
48. Luberto C., Hassler D.F., Signorelli P., Okamoto Y., Sawai H., Boros E., et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 2002, 277:41128-41139.
49. Antosiewicz J., Ziolkowski W., Kaczor J.J., Herman-Antosiewicz A. Tumor necrosis factor-alpha-induced reactive oxygen species formation is mediated by JNK1-dependent ferritin degradation and elevation of labile iron pool. Free Radic Biol Med 2007, 43:265-270.
50. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997, 185:1481-1486.
51. Temkin V., Huang Q., Liu H., Osada H., Pope R.M. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol 2006, 26:2215-2225.
52. Han W., Li L., Qiu S., Lu Q., Pan Q., Gu Y., et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007, 6:1641-1649.
53. Xuan Y., Hu X. Naturally-occurring shikonin analogues-a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett 2009, 274:233-242.
54. Fu Z., Deng B., Liao Y., Shan L., Yin F., Wang Z., et al. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Cancer 2013, 13:580.
55. Huang C., Luo Y., Zhao J., Yang F., Zhao H., Fan W., et al. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One 2013, 8:e66326.
56. Basit F., Cristofanon S., Fulda S. Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ 2013, 20:1161-1173.
57. Bonapace L., Bornhauser B.C., Schmitz M., Cario G., Ziegler U., Niggli F.K., et al. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest 2010, 120:1310-1323.
58. Rizzi F., Naponelli V., Silva A., Modernelli A., Ramazzina I., Bonacini M., et al. Polyphenon E(R), a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis. Carcinogenesis 2014, 35:828-839.
59. Dunai Z.A., Imre G., Barna G., Korcsmaros T., Petak I., Bauer P.I., et al. Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS One 2012, 7:e41945.
60. Deeraksa A., Pan J., Sha Y., Liu X.D., Eissa N.T., Lin S.H., et al. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene 2013, 32:2973-2983.
61. Locatelli S.L., Cleris L., Stirparo G.G., Tartari S., Saba E., Pierdominici M., et al. BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts. Leukemia 2014, [E-pub ahead of print].
62. Liu X., Chhipa R.R., Nakano I., Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther 2014, 13:596-605.
63. Wallenberg M., Misra S., Wasik A.M., Marzano C., Bjornstedt M., Gandin V., et al. Selenium induces a multi-targeted cell death process in addition to ROS formation. J Cell Mol Med 2014, 18:671-684.
64. Saddoughi S.A., Gencer S., Peterson Y.K., Ward K.E., Mukhopadhyay A., Oaks J., et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med 2013, 5:105-121.
65. Pasupuleti N., Leon L., Carraway K.L., Gorin F. 5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor. J Pharmacol Exp Ther 2013, 344:600-615.
66. Zec M., Srdic-Rajic T., Krivokuca A., Jankovic R., Todorovic T., Andelkovic K., et al. Novel selenosemicarbazone metal complexes exert anti-tumor effect via alternative, caspase-independent necroptotic cell death. Med Chem 2014, [E-pub ahead of print].
67. Tufo G., Jones A.W., Wang Z., Hamelin J., Tajeddine N., Esposti D.D., et al. The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma. Cell Death Differ 2014, 21:685-695.
68. Jouan-Lanhouet S., Arshad M.I., Piquet-Pellorce C., Martin-Chouly C., Le Moigne-Muller G., Van Herreweghe F., et al. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ 2012, 19:2003-2014.
69. Vanlangenakker N., Vanden Berghe T., Bogaert P., Laukens B., Zobel K., Deshayes K., et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 2011, 18:656-665.
70. Laukens B., Jennewein C., Schenk B., Vanlangenakker N., Schier A., Cristofanon S., et al. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor alpha-induced necroptosis. Neoplasia 2011, 13:971-979.
71. Steinhart L., Belz K., Fulda S. Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis. Cell Death Dis 2013, 4:e802.
72. Thapa R.J., Nogusa S., Chen P., Maki J.L., Lerro A., Andrake M., et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 2013, 110:E3109-E3118.
73. Coupienne I., Fettweis G., Rubio N., Agostinis P., Piette J. 5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma. Photochem Photobiol Sci 2011, 10:1868-1878.
74. Nehs M.A., Lin C.I., Kozono D.E., Whang E.E., Cho N.L., Zhu K., et al. Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery 2011, 150:1032-1039.
75. Nomura M., Ueno A., Saga K., Fukuzawa M., Kaneda Y. Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma. Cancer Res 2014, 74:1056-1066.
76. Horita H., Frankel A.E., Thorburn A. Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms. PLoS One 2008, 3:e3909.